Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial.
about
Contemporary use of P2Y12 inhibitors in patients with ST-segment elevation myocardial infarction referred to primary percutaneous coronary interventions in Poland: Data from ORPKI national registry.The quest for safer antithrombotic treatment regimens in patients with coronary artery disease: new strategies and paradigm shifts.Antiplatelet Therapy in ACS Patients: Comparing Appropriate P2Y12 Inhibition by Clopidogrel to the Use of New P2Y12 Inhibitors.[Platelet inhibition in patients with coronary, cerebral and peripheral macroangiopathy : What, when and how long?]The year in cardiology 2017: acute coronary syndromes.The year in cardiology 2017: coronary interventions.Incidence, Predictors, and Clinical Impact of Early Prasugrel Cessation in Patients With ST-Elevation Myocardial Infarction.Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary intervention.Optimal duration of dual antiplatelet therapy for coronary artery disease.Individualized Antiplatelet Therapy: A Long Way to Go.Comparative Review of Oral P2Y12 Inhibitors.Relationship between high platelet reactivity on clopidogrel and long-term clinical outcomes after drug-eluting stents implantation (PAINT-DES): a prospective, propensity score-matched cohort study.De-Escalation of P2Y12 Receptor Inhibitor Therapy after Acute Coronary Syndromes in Patients Undergoing Percutaneous Coronary InterventionNovel aspects of antiplatelet therapy in cardiovascular diseaseLandmark Trials in Cardiology in 2017-Celebrating 40 Years of Angioplasty
P2860
Q47707224-CDE58B29-838E-4FA9-97C3-11D31AB21C5BQ47865745-2048EA2F-6B74-454F-A474-11467DF0AE86Q48507719-E0B355F8-64DF-4BD5-AC8D-83132EA54D7BQ50014351-DB24E98D-8D19-4D38-9D7B-569B8892040FQ50193541-64C9547A-7BE2-4F77-A401-EC7CA99BA04EQ50193633-EFE665CE-9F89-4E76-8ECF-93466FC27452Q52589129-E3E43AB2-FC13-481C-A29C-51C4E1E29849Q52593402-80ECC6CE-0838-41A5-827D-AEDB720D3752Q55311019-31AF3DF5-F5C1-4DD3-B932-426865590A39Q55384929-43EA4938-7433-4631-8DD4-EA2792A45B2EQ55396201-E93DBA71-64A8-4A8E-B3AE-22087C9A6A51Q55405593-06C265C1-1063-4084-BB0C-075DE6433722Q57143053-50C355B5-F4A8-4463-A023-05297C443866Q57179203-5427500C-9EE9-4C26-847E-EF1ECD9E62ADQ57665137-AA7961AE-5162-4DFB-992C-D68B0737A7E2
P2860
Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Guided de-escalation of antipl ...... open-label, multicentre trial.
@en
Guided de-escalation of antipl ...... open-label, multicentre trial.
@nl
type
label
Guided de-escalation of antipl ...... open-label, multicentre trial.
@en
Guided de-escalation of antipl ...... open-label, multicentre trial.
@nl
prefLabel
Guided de-escalation of antipl ...... open-label, multicentre trial.
@en
Guided de-escalation of antipl ...... open-label, multicentre trial.
@nl
P2093
P1433
P1476
Guided de-escalation of antipl ...... open-label, multicentre trial.
@en
P2093
András Komócsi
Béla Merkely
Claudius Jacobshagen
Csaba A Dézsi
Dietmar Trenk
Dirk Sibbing
Dániel Aradi
Franz-Josef Neumann
Johannes Rieber
Kurt Huber
P356
10.1016/S0140-6736(17)32155-4
P407
P577
2017-08-25T00:00:00Z